CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Seres Therapeutics Inc. (MCRB) on Tuesday reported a loss of $19.9 million in its first quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $2.08.
The drug developer posted revenue of $358,000 in the period.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/MCRB
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
